Everest Medicines, a Chinese biotech start-up backed by CBC Group, performed strongly in early trading in Hong Kong following a HK$3.5 billion ($451 million) IPO.
Everest sold about 63.5 million shares at HK$55 apiece, the upper end of the indicative range. The stock opened at $HK70.55 on October 9 and was trading at HK$75 as of midday. The company has raised...
Hitachi has agreed to sell its Japan-based radiation measurement devices and industrial x-ray CT devices businesses to local private equity firm Nippon Mirae Capital.
MBK Partners has agreed to buy five ocean theme parks in China – four operational and one under construction – from Hong Kong-listed Haichang Ocean Park Holdings for RMB6.53 billion ($1.01 billion).
Trustar Capital, formerly known as CITIC Capital Partners, has invested an undisclosed sum in Intramco, a Europe-based manufacturer of components used in electric vehicle (EV) charging.
Vitalbridge Capital, a China-based venture capital firm that spun out from Trustbridge Partners, has raised $275 million for its second US dollar-denominated fund.